PROTIA INC. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,805 KRW | -1.75% |
|
+1.45% | -14.22% |
| 2022 | ProteomeTech Inc. has filed an IPO. | CI |
| 2019 | ProteomeTech Inc. announced that it has received KRW 4.999995 billion in funding from POSCO Venture Capital Co., Ltd. and another investor | CI |
More news
| 1 day | -1.75% | ||
| 1 week | +1.45% | ||
| Current month | -1.92% | ||
| 1 month | -1.92% | ||
| 3 months | -3.44% | ||
| 6 months | +2.94% | ||
| Current year | -14.22% |
1 week
2 725.00
2 855.00
1 month
2 705.002 925.00
Current year
2 650.003 410.00
1 year
2 650.007 800.00
3 years
2 650.008 960.00
5 years
2 650.0017 350.00
10 years
2 650.0017 350.00
| Managers | Title | Age | Since |
|---|---|---|---|
Kook-Jin Lim
CEO | Chief Executive Officer | 63 | 01/10/01 |
Myeong-Suk Jeong
BRD | Director/Board Member | 64 | 01/10/01 |
Bum-Jun Kim
BRD | Director/Board Member | 56 | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Kook-Jin Lim
CEO | Chief Executive Officer | 63 | 01/10/01 |
Bum-Jun Kim
BRD | Director/Board Member | 56 | - |
Yu-Sam Kim
BRD | Director/Board Member | 81 | - |
Protia Inc, formerly ProteomeTech Inc is a company mainly engaged in the production and sale of diagnostic kits. The Company mainly produces allergy diagnostic reagents, allergy diagnostic equipment, point-of-care diagnosis products (POCT), among others. In addition, the Company is engaged in provision of protein related analysis services.
| 1st Jan change | Capi. | |
|---|---|---|
| -14.22% | 26.1M | |
| -9.59% | 7.67B | |
| -0.34% | 5.41B | |
| +24.48% | 4.62B | |
| +0.02% | 4.57B | |
| -53.32% | 3.22B | |
| +6.42% | 2.59B | |
| -14.64% | 2.05B | |
| -8.29% | 1.79B | |
| 0.00% | 1.76B |
- Stock Market
- Equities
- A303360 Stock
